Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8-MyD88-NF-B-NLRP3 Inflammasome Pathway

被引:74
作者
Yang, Bing-You [1 ]
Cheng, Yan-Gang [1 ]
Liu, Yan [1 ]
Liu, Yuan [1 ]
Tan, Jin-Yan [1 ]
Guan, Wei [1 ]
Guo, Shuang [1 ]
Kuang, Hai-Xue [1 ]
机构
[1] Heilongjiang Univ Chinese Med, Minist Educ, Key Lab Chinese Mat Med, Harbin 150040, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
psoriasis; Datura metel L; imiquimod; inflammatory cytokines; toll-like receptor 7/8; NF-KAPPA-B; QUALITY-OF-LIFE; NLRP3; INFLAMMASOME; METABOLIC SYNDROME; SKIN INFLAMMATION; DENDRITIC CELLS; MOUSE MODEL; MICE; SECRETION; WITHANOLIDES;
D O I
10.3390/molecules24112157
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Psoriasis is a chronic, immune-mediated inflammatory skin disease, and the inflammatory response plays an important role in its development and progression. Datura metel L. is a traditional Chinese medicine that exhibited a significant therapeutic effect on psoriasis in our previous study due to its remarkable anti-inflammatory effect. Meanwhile, the mechanism underlying its effects on psoriasis is still unclear. Methods: An imiquimod-induced psoriasis-like dermatitis mouse model was constructed to evaluate the protective effect of the effective part of Datura metel L. (EPD), which was verified by evaluations of the Psoriasis Area and Severity Index (PASI) score. Hematoxylin and eosin (H&E) staining, immunohistochemical examination, enzyme-linked immunosorbent assay (ELISA), and Western blot were used to measure the inflammatory cytokines and the protein expression associated with the Toll-like receptor 7- myeloid differentiation primary response gene 88-nuclear Factor-B-nucleotide-binding oligomerization domain (Nod)-like receptor family pyrin domain-containing 3 (TLR7/8-MyD88-NF-B-NLRP3) inflammasome pathway. Results: EPD significantly decreased the PASI, reduced epidermal thickness, and decreased the proliferation and differentiation of epidermal cells in psoriasis-like dermatitis C57BL/6 mice induced by imiquimod (IMQ). Furthermore, EPD reduced the infiltration of CD3+ cells to psoriatic lesions, as well as ameliorated the elevations of intercellular adhesion molecule 1 (ICAM-1) and inhibited the production of imiquimod-induced inflammatory cytokines, including IL-1, IL-2, IL-6, IL-10, IL-12, IL-17, IL-22, IL-23, tumor necrosis factor- (TNF-), monocyte chemotactic protein 1 (MCP-1), and interferon- (IFN-). Besides, EPD decreased the imiquimod-induced expression levels of TLR7, TLR8, TRAF6, MyD88, p-IKK, p-IKB, p-NF-B, NLRP3, apoptosis-associated speck-like protein contained a caspase recruitment domain (ASC), cysteinyl aspartate specific proteinase 1 (caspase-1), and IL-1. Conclusion: This study demonstrated that EPD exhibited a protective effect on an imiquimod-induced psoriasis mice model by inhibiting the inflammatory response, which might be ascribed to the inhibition of the TLR7/8-MyD88-NF-b-NLRP3 inflammasome pathway.
引用
收藏
页数:14
相关论文
共 54 条
[1]   The active compounds derived from Psoralea corylifolia for photochemotherapy against psoriasis-like lesions: The relationship between structure and percutaneous absorption [J].
Alalaiwe, Ahmed ;
Hung, Chi-Feng ;
Leu, Yann-Lii ;
Tahara, Kohei ;
Chen, Hi-Han ;
Hu, Kai-Yin ;
Fang, Jia-You .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 124 :114-126
[2]   Toll-Like Receptor 4 Stimulation Initiates an Inflammatory Response That Decreases Cardiomyocyte Contractility [J].
Avlas, Orna ;
Fallach, Reut ;
Shainberg, Asher ;
Porat, Eyal ;
Hochhauser, Edith .
ANTIOXIDANTS & REDOX SIGNALING, 2011, 15 (07) :1895-1909
[3]  
Bech Rikke, 2016, Mol Cell Ther, V4, P1
[4]   Toll-like receptor 4 in CNS pathologies [J].
Buchanan, Madison M. ;
Hutchinson, Mark ;
Watkins, Linda R. ;
Yin, Hang .
JOURNAL OF NEUROCHEMISTRY, 2010, 114 (01) :13-27
[5]   Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility [J].
Carlstrom, Maria ;
Ekman, Anna-Karin ;
Petersson, Stina ;
Soderkvist, Peter ;
Enerback, Charlotta .
EXPERIMENTAL DERMATOLOGY, 2012, 21 (12) :932-937
[6]   Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway [J].
Chen, Haiming ;
Lu, Chuanjian ;
Liu, Huazhen ;
Wang, Maojie ;
Zhao, Hui ;
Yan, Yuhong ;
Han, Ling .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 48 :110-117
[7]   Metabolic syndrome and psoriasis severity in South-East Asian patients: An investigation of potential association using current and chronological assessments [J].
Chularojanamontri, Leena ;
Wongpraparut, Chanisada ;
Silpa-Archa, Narumol ;
Chaweekulrat, Pichanee .
JOURNAL OF DERMATOLOGY, 2016, 43 (12) :1424-1428
[8]   Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions [J].
Davidovici, Batya B. ;
Sattar, Naveed ;
Joerg, Prinz C. ;
Puig, Luis ;
Emery, Paul ;
Barker, Jonathan N. ;
van de Kerkhof, Peter ;
Stahle, Mona ;
Nestle, Frank O. ;
Girolomoni, Giampiero ;
Krueger, James G. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (07) :1785-1796
[9]   Quality of life in patients with psoriasis: A systematic literature review [J].
de Korte, J ;
Sprangers, MAG ;
Mombers, FMC ;
Bos, JD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2004, 9 (02) :140-147
[10]   PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines [J].
Dou, Rongkun ;
Liu, Zongying ;
Yuan, Xue ;
Xiangfei, Danzhou ;
Bai, Ruixue ;
Bi, Zhenfei ;
Yang, Piao ;
Yang, Yalan ;
Dong, Yinsong ;
Su, Wei ;
Li, Diqiang ;
Mao, Canquan .
PLOS ONE, 2017, 12 (05)